Short Communications 7
Depression 2 - Clinical (2)

[SC7-3] Plasma Phosphoethanolamine Levels as a Biomarker for Monitoring Major Depressive Disorder

*Noriyuki Kawamura¹, Akinori Nakata², Tsuyoto Harada¹, Yoshiaki Ohashi³, Hajime Sato³, kazunori Sasaki³, Teruhiko Higuchi⁴ (1. Gyouki-Kai Medical Corporation, 2. Graduate School of Public Health, International University of Health and Welfare, Tokyo, Japan, 3. Human Metabolome Technologies, Yamagata, Japan, 4. Japan Depression Center,, Tokyo, Japan)

キーワード：MDD biomarker, Monitoring Biomarker, Plasma Phosphoethanolamine (PEA) Levels